Center for Biomarkers and Biotechnology and Drugs, Kaohsiung Medical University. Currently, the center is responsible for implementing the Program for Translational Innovation of Biopharmaceutical Development-Technology Supporting Platform Axis (TSPA)-NP3 service platform. We provide three kinds of antibody genetic engineering related services. Assisting domestic and foreign academic institutions or industry for antibody gene cloning and antibody, accelerating the translation of antibody drugs and its industrialization.
If you have any related needs and problems on the service, you are welcome to contact us or fill out the service inquiry form, we will have someone to contact you, thank you.